#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Intracranial germ cell tumour Hypertriglyceridaemia Pleural mesothelioma Breast cancer metastatic Acute myeloid leukaemia recurrent Follicular lymphoma stage III Neuronal ceroid lipofuscinosis Nephrotic syndrome Neonatal asphyxia Chronic myeloid leukaemia Pustular psoriasis Small cell lung cancer recurrent Pneumonia Metastases to central nervous system Retinopathy of prematurity More trials…

    Learn about Rare Diseases

    Stevens-Johnson syndrome – Trials in Disease Chondrosarcoma – Life with Disease Ocular melanoma Hereditary ataxia – Trials in Disease Hereditary optic atrophy – Trials in Disease Soft tissue sarcoma – Diagnostics Pulmonary sarcoidosis – Life with Disease Haemophilia B without inhibitors – Diagnostics Congenital nephrogenic diabetes insipidus Nodal marginal zone B-cell lymphoma – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Naxitamab Specific Nucleic Acid Sna-Ebv Donidalorsen Doxylamine Hydrogen Succinate Ublituximab Autologous Microfat Pitolisant Alrefimotide Bempikibart Peppermint Oil Siponimod Jnj-81241459 Danicamtiv Gt005 Fosphenytoin Sodium Zanamivir Biotin Ruxotemitide Galunisertib Amoxicillin More therapies…

    Learn about Your Condition

    Mucopolysaccharidosis III Micrographic skin surgery Asymptomatic HIV infection Multiple sclerosis Hypoalbuminaemia Frostbite Cleft lip and palate Methylmalonic acidaemia Hyperphagia Bile duct cancer Poor quality sleep Obstructive pancreatitis Neuropathy peripheral Familial mediterranean fever Anaemia of pregnancy More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Hemic and Lymphatic Diseases

  • Study Comparing Oral Azacitidine and Cedazuridine with Subcutaneous Azacitidine for Patients with Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Chronic myelomonocytic leukaemia
    • Myelodysplastic syndrome
    Investigated Drugs:
    • Cedazuridine
    • Azacitidine
    Czechia France Germany Hungary Italy Poland +1

  • Study on Rilzabrutinib for Patients Aged 10-65 with Sickle Cell Disease

    Recruiting

    3 1
    Investigated Drugs:
    • Rilzabrutinib
    Belgium France Germany Greece Italy The Netherlands +1

  • Study on the Safety and Effects of BMS-986470 for Patients with Sickle Cell Disease

    Recruiting

    2 1
    Investigated Drugs:
    • BMS-986470
    France Italy

  • Study on Epcoritamab for Patients with Relapsed or Refractory Large B Cell Lymphoma

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Tafasitamab
    • Epcoritamab
    • Lenalidomide
    Spain

  • Study of Lisaftoclax combined with azacitidine for elderly patients with newly diagnosed acute myeloid leukemia

    Recruiting

    3 1 1
    Investigated Drugs:
    • Azacitidine
    • Lisaftoclax
    Italy Poland Spain

  • Study on the Safety and Effectiveness of Emicizumab for Patients with Type 3 Von Willebrand Disease

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Von Willebrand’s disease
    Investigated Drugs:
    • Efmoroctocog Alfa
    • Eptacog Alfa (Activated)
    • Factor Viii Inhibitor Bypassing Fraction
    Belgium France Germany Italy The Netherlands Poland +2
Previous Page
1 … 8 9 10 11 12 … 89
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!